HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CCT239065

Also Known As:

1-(5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl)-3-(2-methylsulfanyl-4-((3-oxo-4H-pyrido(2,3-b)pyrazin-8-yl)oxy)phenyl)urea; V600E BRAF inhibitor

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrazines: 150
    - CCT239065: 1
  - Pyridines: 88
    - CCT239065: 1
Organic Chemicals: 133
- Amides: 2428
  - Urea: 15015
    - CCT239065: 1

Experts

1.	Coffey, Robert J: 1 article (03/2013)
2.	Fu, Allie: 1 article (03/2013)
3.	Manning, H Charles: 1 article (03/2013)
4.	McKinley, Eliot T: 1 article (03/2013)
5.	Saleh, Samir A: 1 article (03/2013)
6.	Smith, R Adam: 1 article (03/2013)
7.	Uddin, Md Imam: 1 article (03/2013)
8.	Washington, M Kay: 1 article (03/2013)
9.	Zhao, Ping: 1 article (03/2013)

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 03/01/2013 - "Human colorectal cancer (CRC) cell lines expressing (V600E)BRAF were used to explore relationships between upregulation of p27 and phosphorylation of BRAF downstream effectors on small-molecule (V600E)BRAF inhibitor exposure. "